Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
Analytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisEureka AI Inside
Professional Services
Customer Stories
Blog
Global Innovation Report
Glossary
Newsroom
Webinars & Training
Frontier
User Community
Trust and Security
PatentBench
LLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report Tezepelumab, itepekimab, and next-gen bispecific alarmin blockers are reshaping severe asthma biologics. Explore the patent landscape and pipeline signals.
Article | Report Explore the 2026 bispecific antibody manufacturing patent landscape: Fc engineering, continuous bioprocessing, Chinese biotech filings, and emerging format strategies.
Article | Report A deep analysis of bispecific antibody manufacturing patent landscape 2026: Fc engineering, continuous bioprocessing, Chinese biotech filings, and emerging format strategies.
Article | Report How next-generation anti-amyloid antibodies, bispecific platforms, and tau-targeting modalities are reshaping the Alzheimer's disease pipeline after lecanemab's approval.
Article | Report How psilocybin, 5-MeO-DMT, LSD and novel analogues are reshaping the patent landscape for treatment-resistant depression and PTSD. Deep-dive analysis.
Article | Report How foundation model fine-tuning transforms PCB automated optical inspection: patent intelligence covering hybrid pipelines, CLIP-based prompt learning, and continual learning.
Article | Report Mapping the 2026 autonomous robotic surgery patent landscape: AI navigation, collision avoidance, tendon-drive control, and the assignees shaping surgical autonomy.
Article | Report Small molecules, cyclic peptides, oral ASOs and combination strategies targeting PCSK9 in ASCVD — a patent-driven analysis of the next-generation pipeline.
Article | Report How foundation model fine-tuning transforms PCB automated optical inspection: patent intelligence across 40+ filings from Siemens, Bosch, Tsinghua & more.
Article | Report A 2026 patent landscape analysis of autonomous robotic surgery: AI navigation, collision avoidance, tendon-drive control, and the top assignees shaping the field.
Article | Report How milvexian and asundexian are reshaping stroke prevention by targeting Factor XIa — Phase II data, patent landscape, and pipeline strategy decoded.
Article | Report How proof-load testing, certified process data sets, and in-situ sensors enable AS9100 qualification of flight-critical additively manufactured metal parts.
Article | Report A 2026 patent landscape analysis of High-NA EUV lithography: LPP sources, projection optics, mask technology, and who holds the key IP positions.
Article | Report How GLP-1/amylin co-agonists like CagriSema and Amycretin are reshaping the obesity drug pipeline — IP landscape, assignee strategy, and emerging tri-agonist directions.
Article | Report Electrochemical CO₂ reduction patent landscape 2026: catalyst innovation, MEA architecture, cascade reactors, and emerging IP strategies across 12 years of filings.